This excerpt taken from the TPTX 8-K filed Jun 8, 2006.
Dr. Michael Murphy, Chief Medical Officer
Prior to joining TorreyPines Therapeutics in 2004, Dr. Murphy was Chief Medical and Scientific Officer for Ingenix Pharmaceutical Services, a division of UnitedHealth Group (UHG), and he also served as liaison with other UHG business units in matters of clinical trial design, regulatory activities and other programs of research. Prior to its acquisition by UHG, Dr. Murphy was Vice President of Scientific Affairs at Worldwide Clinical Trials. Previously, he served as Senior Vice President, Worldwide Clinical Research at Cephalon, Inc., and Vice President, Scientific and Professional Affairs, Neuroscience-Strategic Business Unit, at Hoechst-Roussel Pharmaceuticals.